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Background:Oligomers of amyloid- peptides are implicated in the etiology of Alzheimer disease.
Results: Specific “off-pathway” oligomers of A42 show unique replication properties upon interacting with monomers.
Conclusion: The results indicate that oligomers that are formed along pathways outside the fibril formation pathway may
undergo replication.
Significance:Mechanistic details of A soluble oligomers will enable better understanding of Alzheimer disease pathology.
Aggregates of amyloid- (A) peptides have been implicated
in the etiology of Alzheimer disease. Among the different forms
ofA aggregates, lowmolecularweight species ranging between
2- and 50-mers, also called “soluble oligomers,” have emerged
as the species responsible for early synaptic dysfunction and
neuronal loss. Emerging evidence suggests that the neurotoxic
oligomers need not be formed along the obligatory nucleation-
dependant fibril formation pathway. In our earlier work, we
reported the isolation of one such “off-pathway” 12–18-mer
species of A42 generated from fatty acids called large fatty
acid-derived oligomers (LFAOs) (Kumar, A., Bullard, R. L.,
Patel, P., Paslay, L. C., Singh, D., Bienkiewicz, E. A., Morgan,
S. E., and Rangachari, V. (2011) PLoS One 6, e18759). Here, we
report the physiochemical aspects of LFAO-monomer interac-
tions as well as LFAO-LFAO associations in the presence of
interfaces.We discovered that LFAOs are a replicating strain of
oligomers that recruit A42 monomers and quantitatively con-
vert them into LFAO assemblies at the expense of fibrils, a
mechanism similar to prion propagation.We also found that in
the presence of hexane-buffer or chloroform-buffer inter-
faces LFAOs are able to associate with themselves to form
larger but non-fibrillar aggregates. These results further sup-
port the hypothesis that low molecular weight oligomers can
be generated via non-fibril formation pathways. Further-
more, the unique replicating property of off-pathway oligo-
mers may hold profound significance for Alzheimer disease
pathology.
Formation of assemblies by a protein called amyloid- (A)2
peptide in the cortical and hippocampal regions of the brain is
mainly responsible for the cognitive decline and memory loss
that occur in Alzheimer disease (AD). The brains of AD
patients contain a large number of insoluble proteinaceous
aggregates that are deposited as senile plaques. These aggre-
gates are mainly composed of 40- and 42-amino acid-long pep-
tides called A40 and A42, respectively (2). An overwhelming
body of evidence has emerged in recent years that disputes the
classic “amyloid cascade theory” and implicates the smaller,
soluble aggregates as the primary neurotoxins responsible for
neuronal loss as opposed to the fibrils (3–8). Studies have indi-
cated that soluble oligomers, not the plaque load, in both cell
culture and transgenic animalmodels are not only toxic but also
better correlate with the level of cognitive disability (8–10).
Several such observations suggest that low molecular weight
(LMW) “soluble oligomers” ranging between 2- and 50-mers
are involved in the early synaptic dysfunction in AD (3, 5, 7, 11).
Needless to say, this has led to an unprecedented focus on iden-
tifying and characterizing smaller LMW aggregates of A both
in vitro and in vivo.
The process of A aggregation is a nucleation-dependent
phenomenon in which the formation of a critical mass of a
self-assembled aggregates called the “nucleus” along with a
concomitant conformational change is a prerequisite for the
emergence of mature fibrils. Such a mechanism generates a
classic sigmoidal growth curve containing a lag phase prior to
the growth phase. In this process, it is clear that smaller oligo-
mers, which are the intermediates of fibril formation, are
formed transiently along the pathway. However, it is becoming
evident from many recent reports that there are alternative* This work was supported, in whole or in part, by National Institutes of Health
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pathways of aggregation (12–14) and that neurotoxic oligomers
can also be populated via alternate pathways (15–17). Recently,
a 12–16-mer oligomeric species of A42 called “globulomers”
was reported to be formed independently of the fibril formation
pathway (18), and a similar observation was reported for a
9–15-mer species generated in the presence of SDS (19).More-
over, annular protofibrils (APFs) formed from prefibrillar olig-
omers (PFOs) failed to convert to fibrils even after an extended
period of time, suggesting that these pathogenic oligomers are
formed outside the nucleation-dependant fibril formation
pathway (20). Reports such as these have shown that there are
multiple pathways of aggregation that compete with fibril for-
mation, especially during the prenucleation stage, giving rise to
several kinds of oligomers. Therefore, it is important to under-
stand the physiological consequence of such a process. One
property of “off-pathway” oligomers is that they convert to
fibrils, if at all, at a much slower rate than the fibril formation
“on-pathway” counterparts and hence possess longer half-lives.
This in turn can result in prolonged toxicity to the neuronal
cells and therefore has profound significance in AD pathology.
Unfortunately, there is a paucity of structural, mechanistic, and
pathological understanding of LMW oligomers in general and
more so with the oligomers that are not formed along the fibril
formation pathway. In our previous work, we reported that
non-esterified fatty acid (NEFA) interfaces can inducemultiple
pathways of A aggregation in carefully controlled conditions
of NEFA concentrations and A-to-NEFA molar ratios (1).
More importantly, we reported that two distinct off-pathway
oligomers of A42 can be generated: 4–5-mers (small fatty
acid-derived oligomers) and 12–18-mers (large fatty acid-de-
rived oligomers (LFAOs)). Here, we report the isolation and
characterization of LFAOs along with two important physio-
chemical properties. (a) LFAOs seem to be a replicating species
that quantitatively convert A42 monomers into LFAOs at the
expense of fibrils, a mechanism similar to prion protein propa-
gation. (b) In the presence of interfaces, LFAOs are able to form
larger but non-fibrillar diffuse aggregates, further supporting
our hypothesis on alternate aggregation pathways.
EXPERIMENTAL PROCEDURES
Materials
A42was synthesized by the Peptide Synthesis Facility at the
Mayo Clinic (Rochester, MN) using routine Fmoc (N-(9-fluo-
renyl)methoxycarbonyl) chemistry. MALDI-TOF mass spec-
trometry revealed 90% purity of the peptide. Sodium dode-
cylsulfate (SDS) and thioflavin-T (ThT) were procured from
Sigma. Lauric acid (C12:0) fatty acid was purchased as a sodium
salt fromNuCheck Prep Inc. (Elysian,MN). All other chemicals
were obtained from VWR Inc.
Preparation of A42 Monomers
Lyophilized stocks of synthetic A42 were stored at 20 °C
desiccated. Briefly, 1.5–2 mg of peptide was dissolved in 0.5 ml
of 30 mM NaOH and stored for 15 min at room temperature
prior to size exclusion chromatography (SEC) onto a 1 30-cm
Superdex-75 HR 10/30 column (GE Healthcare) attached to an
ÄKTA FPLC system (GEHealthcare) to remove any preformed
aggregates as reported previously (1). The column was pre-
equilibrated in 20 mM Tris-HCl (pH 8.0) at 25 °C and run at a
flow rate of 0.5 ml/min. One-minute fractions were collected.
Concentrations of A were determined by UV-visible spec-
trometry on a Cary 50 spectrophotometer (Varian Inc.) using a
molar extinction coefficient of 1450 cm1 M1 at 276 nm
(ExPASy) corresponding to the single tyrosine residue in A42.
Peptide integrity after SEC was again confirmed by MALDI-
TOFmass spectrometry, which showed amonoisotopicmolec-
ular mass of 4516.31 Da in good agreement with a calculated
mass of 4513.13 Da. Monomeric A42 fractions were stored at
4 °C and used within 2–5 days of SEC purification in all exper-
iments to avoid any preformed aggregates in our reactions.
A Aggregation Reactions
Preparation and Isolation of LFAOs—LFAOs were prepared
and isolated as described previously (1). Briefly, the freshly
purified A42 (50 M) was incubated with 50 mM NaCl and 5
mMC12:0 fatty acid at 37 °C for 48 h. After 48 h, the sample was
subjected to SEC, and the fractions corresponding to the peak
near the void volume (V0) were collected. Concentrations of
collected fractions were determined by UV absorbance. All iso-
lated LFAO fractions were stored at 4 °C and usedwithin 2 days
after SEC isolation in all experiments.
Agitation Experiments with Hexane-Buffer and Chloroform-
Buffer Interfaces—To freshly purified 2 M LFAO or A42
monomer (control) in 20 mM Tris (pH 8.0), 5% (v/v) hexane
(  0.6548 g/ml) and chloroform (  1.483 g/ml) were added
independently and mixed vigorously using a vortex mixer for 1
min of agitation followed by 5 min of rest. After eight cycles of
agitation (1 h), the samples were then dialyzed against 20 mM
Tris-HCl (pH 8.0) at 25 °C using a 2-kDa-molecular mass-cut-
off Slide-A-Lyzer G2 dialysis cassette (Thermo Scientific) for
23 h. Afterward, the dialyzed samples were subjected to immu-
noblotting, dynamic light scattering (DLS), and atomic force
microscopy (AFM) analyses.
Suspension Experiment with Chloroform-Buffer Interface—
The suspension method reported previously (21) was followed
in our experiments. Freshly purified 2 M LFAO or A42
monomer (control) (0.3 ml) was suspended on top of a 100%
chloroform solution (0.3 ml) in a 1.5-ml siliconized Eppendorf
tube without mixing. The samples were kept at 25 °C for 24 h
without any disturbance. After 24 h, the samples were removed
from just above the interface without disturbing the interface.
The samples from both reactions were subjected to immuno-
blotting, DLS, and AFM analyses.
LFAO Replication Experiment—Monomeric A42 (20 M)
was incubated alone or with 2% (0.4 M) LFAO seed in 20 mM
Tris (pH 8.0) at 25 °C for 72 h. Aliquots of samples were
removed at 0, 24, 48, and 72 h and subjected to immunoblotting
and AFM after spinning at 19,000  g for 20 min. The 0.4 M
LFAOseeds alonewere also used as a control. Similarly, for SEC
isolation of replicated LFAO, 50 M A42 monomer was incu-
bated with 1 M LFAO under the same conditions, keeping the
A42:LFAO ratio the same. Aliquots of samples were removed
at 0, 24, 48, and 72 h and subjected to SEC on a Superdex-75HR
10/30 column after spinning at 19,000 g for 20min to remove
fibrils. Fraction 17 from each SEC fractionation at 0, 24, 48, and
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72 h was subjected to immunoblotting and circular dichroism
(CD).
LFAO Replication Experiment with Dansyl-A42 Monomer—
The above experiment was repeated with dansyl-A42 (Dan-
A42) monomer, which was purified similarly to the wild-type
A42 mentioned above. A freshly purified 50 M Dan-A42
monomer sample was incubated with 1 M LFAO under the
same conditions mentioned above. Aliquots of samples were
removed after 72 h and subjected to SEC on a Superdex-75 HR
10/30 column after spinning at 19,000 g for 20min to remove
fibrils. Fractions 17 and 18 from the SEC fractionation were
subjected to immunoblotting and emission fluorescence spec-
troscopy using aCary Eclipse spectrometer (Varian Inc.) in scan
mode. The dansyl emission was monitored at 450 nm after
exciting at 350 nm using 10-nm slits.
Fluorescence Spectroscopy
ThT fluorescence was monitored in a microcuvette with a
Cary Eclipse spectrometer (Varian Inc.) after 15-fold dilution of
A42 samples into 5 mM Tris-HCl (pH 8.0) containing 10 M
ThT.Continuousmeasurements of fluorescencewere taken for
1minwith the excitation and emissionwavelengths fixed at 450
and 482 nm, respectively, and the excitation and emission slits
set at 10 nm.
Dynamic Light Scattering
The DLS was performed on a Zetasizer Nano S DLS instru-
ment (Malvern Inc., Worcestershire, UK). Each sample meas-
urement consisted of six runs of 10 s each with a pre-equilibra-
tion time of 40 s. After the measurement, the number (%) was
exported and plotted against size using Origin 7.0 software.
Polyacrylamide Gel Electrophoreses (PAGE) and
Immunoblotting
Samples were dissolved in loading buffer (1 Laemmli
buffer) containing 1% SDS, applied without heating to 4–12%
NuPAGE gels (Invitrogen) containing bis-Tris, and resolved in
MES running buffer with 0.1% SDS. Dye-linkedmolecularmass
markers (Blue Plus2 Prestained Standards, Invitrogen) were
run in parallel for calibration. Gels were electroblotted onto
0.45-m nitrocellulose membranes (BioTraceTM NT, Pall Life
Sciences). Blots were boiled in a microwave oven in PBS for 2
min and blocked overnight with 1 PBS containing 5% nonfat
dry milk and 0.1% Tween 20 before probing (1–2 h) with
1:1000–1:2500 dilutions of Ab9 monoclonal antibody, which
detects amino acid residues of A (1–16). Blots were then incu-
bated with anti-mouse horseradish peroxide (HRP) conjugate
and developed with ECL reagent (Thermo Scientific).
Atomic Force Microscopy
Micawas cleaved using a razor blade and taped to amagnetic
sample holder. Themica stubwas then coveredwith a 3-amino-
propyltriethoxysilane solution (500 l of 3-aminopropyltri-
ethoxysilane in 50 ml of 1 mM acetic acid) for 20 min. The
3-aminopropyltriethoxysilane solution was then decanted, and
the mica was rinsed four times with 150 l of deionized water.
After rinsing, the mica stub was dried with compressed N2 gas
and stored in a desiccator for 1 h. Next, 150 l of 0.25–1 MA
sample was added to themica and allowed to adsorb for 30min.
The sample was then decanted, and the mica stub was rinsed
four times with 150l of deionizedwater. Finally, themica stub
was dried with compressed N2 gas and stored in a desiccator
until imaging. The surface topography of each sample was
explored by imaging the peptide after it had been adsorbed onto
3-aminopropyltriethoxysilane-treated, freshly cleaved mica.
These images were obtained via aDimension 3000 atomic force
microscope (Digital Instruments) in tapping mode using
RTESP etched silicon probes (length, 125 mm; nominal force
constant, 40 newtons/m; and resonance frequency, 350 kHz)
(Veeco Instruments). While under ambient environmental
conditions, the scan ratewas held constant at 1Hz. All standard
image-processing techniques were performed on Nanoscope
version 5.30 r2 image analysis software. Nanoscope software
and Gwyddion version 2.7 software were used to calculate fea-
ture heights by two methods: 1) section analysis to extract
height profiles and 2) particle analysis to determine the statis-
tical distribution of pixel heights for individual aggregates. Rep-
resentative height profiles can be found in Fig. 3 and supple-
mental Figs. S4 and S5. Multiple areas were imaged for each
sample, and whereas height, phase, and amplitude data were
collected simultaneously, amplitude images are used most
often in the text to discuss morphology variation between
samples.
Analytical Ultracentrifugation (AUC)
Sample Preparation—FITC-labeled A42 (FITC-A42) was
purchased in a lyophilized form (Bachem Inc.) and stored at
20 °C prior to use. A stock containing 5 mM FITC-A42 in
DMSO was prepared as described previously (18). The stock
was then diluted to 100 M in 20 mM Tris (pH 8.0) and used for
generating FITC-labeled LFAO (FITC-LFAO). Briefly, for the
generation and isolation of FITC-LFAO, 40Mwild-type A42
and 10 M FITC-A42 were incubated with 5 mM C12:0 fatty
acid under the same conditions as described above for LFAO
preparation, and LFAOs were isolated using a similar protocol.
For the replication experiments, monomeric A42 (20M) was
incubatedwith 2% (0.4M) FITC-LFAOseed in 20mMTris (pH
8.0) at 25 °C for 72 h. After 72 h, the sample was subjected to
sedimentation velocity analysis. The 0.4 M FITC-LFAO seeds
alone were used as a control. Similarly, FITC-fibrils were pre-
pared by mixing 45 M WT A42 with 5 M FITC-A42 and
incubating with 150 mM NaCl in 20 mM Tris (pH 8.0) at 37 °C
for 2–3 days. TheThT fluorescencewasmonitored daily until it
reached a plateau. The samplewas then centrifuged at 19,000
g for 20min. The pellet was resuspended in 20mMTris (pH 8.0)
and used for AUC analysis.
Sedimentation Velocity—Samples were mixed by brief vor-
texing and then spun in a tabletop centrifuge for approximately
5 s to ensure that no sample was lost on the walls of the tube.
Samples were then loaded into 1.2-cm-path length sedimenta-
tion velocity cells (Sedvel60) and placed in a Beckman XLA
analytical ultracentrifuge equipped with a fluorescence detec-
tion system (Aviv FDS). The temperature on the centrifuge was
equilibrated until it remained constant at 20 °C for at least 5
min. The centrifuge was then accelerated to 5000 rpm at which
point the focus depth and gain for the fluorescence detection
Replicating Strain of Off-pathway A42 Oligomers
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system were adjusted to maximize the signal collected. The
centrifuge was then accelerated to 60,000 rpm, and data collec-
tion began immediately after final velocity was reached. Each
scan was averaged over five consecutive scans to increase the
signal-to-noise ratio. The run was stopped when the fluores-
cence intensity versus radial distance profiles remained con-
stant between scans, indicating that the boundary had pelleted.
The samples were then rerun for 30 min at 60,000 rpm using
absorbance optics to collect pseudo-absorbance data. All data
were transferred to a separate computer for analysis; the pseu-
do-absorbance data were used to calculate the meniscus posi-
tion for each sample using the meniscus wizard in the software
program DCDT2 (version 2.3.2) (22). The software program
Sedfit (Sedfit89) (23) was used to generate c(s) distributions for
the fluorescence detection system data with 0.1-S resolution.
The c(s) distribution for each sample was integrated and
divided by the area, and all data are presented as normalized c(s)
distributions. The software program Sedfit was also used to
generate c(M) distributions after generating the c(s) distribu-
tion by assuming a constant diffusion coefficient for all samples
and an f/f0 value of 1.2. The c(M) distributions were normalized
using the same method as described for the c(s) distributions.
Circular Dichroism
CD spectra were obtained in the far-UV region with a Jasco
J-815 spectropolarimeter. Samples were placed in a 0.1-cm-
path length quartz cuvette (Hellma) and monitored in contin-
uous scan mode (260–190 nm). The acquisition parameters
were 50 nm/min with 8-s response time, 1-nm bandwidth, and
0.1-nm data pitch, and data sets were the average of two scans.
Spectra of appropriate blanks were subtracted from each data
set as indicated. The corrected, averaged spectra were
smoothed using a “mean movement” algorithm with a convo-
lution width of 25 using the Jasco spectrum analysis program.
RESULTS
LFAOs Are Not Discrete but Disperse Mixture of Oligomeric
Species
In our previous work, we showed that A42 upon incubation
with varying concentrations of NEFAs generates two distinct
types of oligomers, LFAOs (12–18-mers) and small fatty acid-
derived oligomers (4–5-mers), at near and above critical
micelle concentrations of NEFA, respectively (1). In the same
report, we also indicated that LFAOs can be isolated using
Superdex-75 SEC. In the current report, first we quantified the
amount of NEFA (lauric acid), if any, associated with the iso-
lated LFAOs and estimated the molecular size distribution of
LFAOs by SEC andAUC.AnA42 sample incubatedwith buff-
ered 5 mM lauric acid at 37 °C for 48 h was subjected to frac-
tionation on a Superdex-75 SEC column (Fig. 1A, smooth line).
The sample eluted in twomajor peaks, one between fractions 17
and 20 and the other between fractions 22 and 25. In addition, a
small peak near the void volume of the column (fraction 16)was
also observed. Immunoblots of the inclusive volume fractions
22–25 suggested they were A42 monomers consistent with
our previous observation (1) (data not shown). LFAOs eluted in
the partially included volume (fractions 17 and 18) as observed
previously (Fig. 1A). The presence of NEFA was quantified
using a free fatty acid assay kit (BioVision Inc., Milpitas, CA) as
shown previously (24). Such examination indicated only a neg-
ligible amount (0.1%) of NEFA present in these fractions con-
taining isolated LFAOs (supplemental Fig. S1).
To ascertain the molecular mass of LFAOs based on reten-
tion volumes, the SEC profile was comparedwith those of glob-
ular protein standards (gel filtration standard; Bio-Rad cata-
logue number 151-1901) (data not shown). Based on this
analysis, the molecular mass of LFAOs was estimated to be
between 60 and 200 kDa. In addition, protofibrils (PFs) ofA42,
which are high molecular mass species (200,000 Da; 500-
mers), were also generated following a previously established
protocol (25, 26) and subjected to fractionation under similar
conditions. The PF sample exhibited two elution peaks, the PFs
FIGURE 1. Isolation and characterization of LFAOs. A, SEC fractionation of
LFAOs using a Superdex-75 column in 20 mM Tris (pH 8.0) at room tempera-
ture with a flow rate of 0.5 ml/min and a fraction size of 1 ml. As a comparison,
a sample of PFs of A42 was also fractionated. V0 indicates the void volume
based on globular protein standards. Inset, AFM image of fractionated LFAOs
reproduced from Kumar et al. (1). Scale bar, 2.5 m. B, normalized c(s) distri-
bution profile generated from a sedimentation velocity experiment per-
formed at 50,000 rpm. Inset, immunoblot of LFAOs before (B) and after frac-
tionation (fractions 17 and 18). The single arrow indicates the 50 –70-kDa
band, whereas the double arrow indicates the 80 –110-kDa band. The results
shown are a single data set of three independent acquisitions. a.u., absorb-
ance units.
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at the void volume (V0; Fig. 1A, black arrow) at fraction 15 and
monomers at fractions 22–25 (Fig. 1A, dashed line). The PF
fractionation also supported our conclusion with globular pro-
tein standards that the molecular mass of LFAOs is between 60
and 200 kDa. Subjecting the LFAO fractions (fractions 17 and
18) to another cycle of fractionation through SEC yielded 7.3%
monomers, which is comparable with 10.6% obtained in the
first SEC fractionation. This suggests that LFAOs undergo par-
tial dissociation upondilution (supplemental Fig. S2). TheAFM
image of the isolated LFAOs showed largely a bimodal distribu-
tion of non-fibrillar punctate dots ranging between 7–10 and
16–19 nm in height (Fig. 1A, inset).
Themolecular size distribution of LFAOswas also estimated
by sedimentation velocity experiments in an analytical ultra-
centrifuge. As described under “Experimental Procedures,”
FITC-labeled A42 was introduced into the oligomeric assem-
bly as a reporter to allowmonitoring via an analytical ultracen-
trifuge-fluorescence detection system. More importantly,
labeling also reduces the amount of sample needed while
increasing the sensitivity at low concentrations. The c(s) sedi-
mentation coefficient distribution profiles obtained from these
experiments are shown in Fig. 1B. The sizes of the LFAOs were
analyzed both before and after fractionation to observe size
differences if any. The A42 sample in the presence of 5 mM
lauric acid prior to SEC showed a distribution of peaks with a
sharp peak centered around 4 S and a more disperse peak
between 6 and 12 S along with a peak at 1 S (Fig. 1B, dotted
lines). The 1 S peak corresponds to monomeric A as deter-
mined by the control sample (supplemental Fig. S3A). An
immunoblot of the A42 sample incubated in 5 mM lauric acid
prior to SEC indicated a disperse band between 56 and 110 kDa
(Fig. 1B, inset, lane B). The AUC analyses of the SEC-fraction-
ated LFAOs (fraction 17) showed an overall distribution similar
to that prior to SEC fractionation containing predominantly
two species, a main peak centered at 5 S and a second disperse
peak between 7 and 12 S along with somemonomers (1 S) (Fig.
1B, smooth line). As a comparison, we analyzed A42 fibrils
using AUC, which showed a heterogeneous mixture of species
between 40 and 200 S (supplemental Fig. S3B). It is noteworthy
that a considerable decrease in the relative amount of mono-
mers was also observed after fractionation based on the signal:
52.3 and 14.8% monomers before and after fractionation,
respectively. The LFAOs showed a similar distribution of olig-
omers even after a 10 to 50-fold dilution in AUC (data not
shown). It is also noteworthy that recently a similar sedimenta-
tion distribution profile was obtained for amyloid-derived dif-
fusible ligands ofA42 (27). In contrast to the LFAOs, theA42
fibril control showed widely disperse sedimentation coefficient
values between 50 and 200 S (supplemental Fig. S3B). The
immunoblots of both the SEC-fractionated and unfractionated
LFAO samples showed largely a disperse band between 56 and
110 kDa with two distinct band distributions centered around
56–70 and 80–110 kDa (Fig. 1B, inset). The band distributions
in the immunoblots complement the bimodal distributions
observed both in AFM and AUC data. Together, the data sug-
gest that the LFAOs are not discrete oligomeric species but are
a disperse distribution of oligomers ranging between 56 and
110 kDa (12–24-mers).
LFAOs Are Replicating Strains
Typically, “seeding” is a process in which a small amount of
preformed aggregate when added to monomeric A enhances
the aggregation rate towards fibril formation. Because the
aggregate morphology is dependent on the physiochemical
property of the seed itself, we wanted to explore whether
LFAOs can “replicate,” or in other words seed their own forma-
tion, by the addition ofmonomericA, amechanism analogous
to prion protein propagation. This property has been recently
demonstrated by Kayed et al. (28), who reported that specific
soluble oligomers called PFOs were able to seed their own rep-
lication upon interacting with monomeric A. The property of
replication could be a manifestation of the unique structure of
the oligomeric assembly and more importantly may comple-
ment our previously reported hypothesis that such oligomers
are formed along a pathway different from fibril formation (1,
19). To explore this, a 20 M sample of freshly purified, “seed-
free” A42 was incubated with 0.4 M isolated LFAOs as seeds
(2% molar ratio) at room temperature. Aliquots from this sam-
ple were subjected to immunoblotting after 24, 48, and 72 h of
incubation to monitor the reaction progress (Fig. 2A). The
amount of LFAOs loaded in each lane of the SDS-polyacryl-
amide gel was kept constant at 28 ng based on the initial seed
concentration to make quantitative estimates of the blots. The
immunoblot in Fig. 2A showed an LFAO band within 24 h of
incubation with monomers that was clearly more intense com-
pared with the 0-h incubation sample (lane 3). Importantly,
these bands are centered at 100 kDa, which is the higher band
among the two observed for the isolated LFAOs (lane C),
whereas the lower molecular mass (56–70-kDa) band is
absent (Fig. 2A, 24 h). These bands became increasingly more
intense after 48 and 72 h, whereas the intensity of themonomer
bands diminished, suggesting the conversion of monomers to
LFAOs. Also, after 72 h, a high molecular mass species that
failed to enter the gel was observed (lane T; 72 h) that was not
present in the supernatant after the sample was centrifuged at
19,000  g for 20 min. This suggests that with time fibrils
started to emerge, possibly due to monomers progressing
toward on-pathway fibrils independently. This observation is
not surprising considering that the on-pathway fibril formation
reaction is expected to proceed in parallel with monomer-
LFAO interactions. Concomitantly, the replication process was
monitored by ThT fluorescence (Fig. 2C). A42 seededwith 2%
LFAO (Fig. 2C, E) showed only a negligible amount of seeding
with a lag time of 72 versus 84 h for the control (Fig. 2C, f).
It is important to point out that upon seeding with 20% seeds a
significant reduction in lag times was observed in our previous
report (1). The immunoblots recorded during the lag phase (24,
48, and 72 h) showed the presence of a substantial amount of
LFAOs in the seeded samples that was clearly absent in the
control, suggesting that LFAOs had undergone replication dur-
ing this time period. More importantly, the immunoblots also
seem to indicate that the LFAO seeds are able to induce the
formation of the 80–110-kDa oligomers at the expense of
56–70-kDa species observed within the unseeded LFAOs.
We then reasoned that because replication leads to an
increase in the amount of LFAOs formed a quantitative analysis
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would provide further proof of this process. To do so, a higher
concentration of A42 sample, 50 M, was seeded with 1 M
LFAOs (2% molar seed ratio) to facilitate fractionation by SEC
while maintaining a constant ratio of A42:LFAO seed. Immu-
noblots of aliquots at 24, 48, and 72 h time showed a banding
pattern similar to that seen in Fig. 2A (data not shown). The
same aliquotswere also subjected to fractionation by SEC. Prior
to loading onto the Superdex-75 column, the sampleswere cen-
trifuged to remove any fibrils present in the sample, and the
supernatant was subjected to fractionation. As observed before
in Fig. 1A, the samples eluted near the void volume (Fig. 2D,
fractions 16–18), and immunoblotting confirmed that these
species were predominantly LFAOs (Fig. 2B, lane 24 h). The
amount of LFAOs eluted in these fractions increased progres-
sively with time (as inferred by the increase in absorbance),
suggesting a quantitative increase in the amount of LFAOs gen-
erated. Overall, the sample showed a 4-fold increase in the
amount of LFAOs as compared with a non-seeded control after
72 h (Fig. 2D). Importantly, immunoblots for fraction 17 from
SEC also indicated a progressive increase in the amount of
80–100-kDa LFAOs (Fig. 2B). Far-UV CD of the fractionated
sample (fraction 17) also showed a progressive increase in
-sheet conformation, further supporting the increase in LFAO
content upon seeding (Fig. 2E). Finally, to verify the formation
of 80–110-kDa species at the expense of 56–70-kDa species,
the LFAO sample was monitored both before and after replica-
tion by sedimentation velocity analysis after 72 h of incubation
(Fig. 2F). Prior to seeding, amajor specieswas observed thatwas
centered at 60 kDa along with some monomers as observed
previously (Fig. 2F, dotted lines). After replication, the data
clearly showed a shift toward highermolecularmasses (80–110
kDa), complementing the shift in banding pattern toward
higher molecular mass observed in immunoblots (Fig. 2F,
smooth line). A small decrease in the relative amount of mono-
mer (6%) present after seedingwas also observed inAUCdata
(Fig. 2F), further supporting the immunoblot data that indi-
cated that quantitative amounts of monomers are converted to
LFAOs upon initiating the seeding reaction.
AFM images of the supernatants of the seeded samples
shown in Fig. 2A are presented in Fig. 3. Immediately after incu-
bation (Fig. 3, A and D), samples exhibited only a few punctate
spherical particles of 8 nm in height that are attributed to
LFAOs. After 48 h of incubation (Fig. 3, B and E), samples
exhibited a significant increase in the number of spherical
LFAO particles with a slight increase in the height (12 nm)
that seem to align along a longitudinal axis (inset). Samples
imaged after 72 h of incubation (Fig. 3, C and F) showed a
further increase in the number of particles with similar height
(14 nm) with simultaneous presentation of individual punc-
tate spherical particles aligned linearly (inset) and a small num-
ber of smooth fibrillar structures. Importantly, many of these
linearly aligned globular particles presented an overall appear-
ance of “nascent” PFs. It is noteworthy that a similar “ordering”
of spherical particles was observed previously when A40 was
treated in the presence of an aqueous-organic interface (21).
These images support the AUC and immunoblotting data and
indicate that the seeded LFAOs replicate.
Finally, to ensure that monomers are incorporated into the
replicated oligomers, Dan-A42 was used as a fluorescent
probe. We expected that seeding of Dan-A42 with LFAOs
would lead to oligomers containing the labeled peptide, which
can be detected by intrinsic fluorescence as shown in the sche-
matic (Fig. 4A). A seeding experiment was performed as
described above using 50 M Dan-A42 with 1 M LFAOs at
room temperature and subjecting the seeded sample to SEC
fractionation and immunoblotting after 72 h (Fig. 4B). The
immunoblot clearly showed an increase in LFAO formation
after 72 h compared with 0 h (Fig. 4C, lanes 4, 5, and 6). The
immunoblot of the fractionated sample (fractions 17 and 18)
also showed the presence of replicated LFAOs (Fig. 4C, lanes 8
and 9). Clearly, the unreacted monomers fractionated in the
inclusion volume at fraction 24 (Fig. 4C, lane 10). The fluores-
FIGURE 2. LFAOs replicate upon interacting with monomers. A, immuno-
blot of 20 M A42 incubated with 0.4 M LFAO (2% seed) for 72 h at room
temperature before and after SEC. Lane C represents LFAO control (338 ng).
Lanes 1 and 2 are A42 control after 72 h in the absence of LFAO seed and
LFAO alone (28 ng), respectively. Lane 3 is an aliquot of the 20 M A42
seeded with 0.4 M LFAO immediately after incubation (0 h). Lanes T and S
represent the total sample and supernatant of the sample after centrifuga-
tion at 19,000  g for 20 min, respectively, at the indicated times of incuba-
tion. The volume of sample loaded was kept constant to ensure that 28 ng of
the parent LFAO was maintained. B, immunoblot of fraction 17, fractionated
by SEC after 24, 48, and 72 h of incubation of the samples in A (lanes S). C, ThT
fluorescence data of the seeded reaction. The arrow indicates the 72-h point
to which the seeding reaction was monitored. D, fraction 17 of the seeded
samples that were fractioned on a Superdex-75 column after 24, 48, and 72 h
along with a control sample (no seed) after 72 h. E, corresponding far-UV CD
spectra of fraction 17. F, normalized relative molecular mass distributions
(c(M) profiles) obtained from sedimentation velocity data for control LFAOs
(dotted line) and seeded oligomers (smooth line). Inset, expanded region of the
c(M) plot indicated in the figure. The results shown are representative of at
least two reproducible results. F, fluorescence; a.u., absorbance units.
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cence spectra of fractions 17 and 18 obtained by exciting the
sample at 350 nm while monitoring dansyl emission at 450 nm
are shown in Fig. 4D. Both fractions clearly exhibited dansyl
emission at 450 nm, indicating that Dan-A42monomers have
been incorporated into the LFAO assembly during the seeding
reaction, providing unambiguous evidence for such a mecha-
nism. Together, the collective data suggest that LFAOs are a
replicating strain that can induce the formation of similar olig-
omeric species upon interacting with A42 monomers.
LFAOs Form Non-fibrillar, Diffuse Aggregates in Aqueous-
Organic Phase Interfaces
Buffer-Hexane and Buffer-ChloroformAgitation Experiments—
Aqueous-organic phase interfaces have been known to influ-
ence A aggregation tremendously (20). Specifically, prefibril-
lar oligomers formed distinct ring-/porelike structures called
APFs promoted by water-hexane interfaces and failed to form
on-pathway fibrils upon long term incubation (20). We wanted
to explore whether LFAOswere able to form similar non-fibril-
lar aggregates upon exposure to aqueous-organic phase inter-
faces. For these experiments, two interfacial systemswere used:
hexane-water (as reported previously (20)) and chloroform-wa-
ter. First, the freshly isolated LFAOs (2 M) were mixed and
agitated with 5% (v/v) hexane in water following a protocol
described by Kayed and et al. (20) (see “Experimental Proce-
dures”). The agitated sample was dialyzed for 23 h at room
temperature after which the samples were analyzed by DLS.
LFAOs in buffer alone showed a monodisperse peak with a
diameter of10 nm (Fig. 5A, black peak) in agreement with the
7–10-nm range of heights observed in AFM images (Fig. 1A,
inset). In contrast, LFAOs treated in hexane-water showed the
formation of a mixture of large species with a hydrodynamic
diameter of 700 nm (Fig. 5A, gray peak). The corresponding
immunoblot of the sample did not show a high molecular mass
species; however, a sharp decrease in the intensity of the LFAO
band was observed (Fig. 5B, lane 6). It is interesting to note that
the control A42monomers (in the absence of LFAOs) showed
a high molecular mass band that failed to enter the gel upon
similar hexane treatment (Fig. 5B, lane 3).
To see whether the formation of large amorphous aggregates
in hexane can be replicated in other organic solvents, the effect
of chloroform was investigated. Chloroform was used rather
than hexane because it is denser than water, and buffer can be
readily suspended on top of the organic layer. The LFAO sam-
ple (2 M) was incubated with 5% chloroform, agitated, and
dialyzed in a similar fashion as the hexane sample. A polydis-
perse distribution of species containing twomajor peaks (700
and 1000 nm), similar to that observed in the hexane-treated
sample, was obtained by DLS (Fig. 5A, light gray peaks). The
sample treated with chloroform showed a disperse band
between 200 and 260 kDa in the immunoblot (Fig. 5B, lane 5).
FIGURE 3. Morphological changes during LFAO replication. Aliquots of the samples from Fig. 2A (before SEC) were probed at different time points to see the
replication of oligomers after incubating 20 M A42 with 0.4 M LFAO (2% seed) for 72 h at room temperature. A, B, and C represent the amplitude AFM images
of seeded sample after 0, 48, and 72 h, respectively (z scale, 0 – 0.8 V). D, E, and F represent the corresponding height data from A, B, and C, respectively (z scale,
0 – 40 nm). The white scale bar represents 2.5 m, and the inset shows a field of dimensions 1  1 m surrounding the particles indicated with arrows. The white
boxes in D–F indicate the particles for which height analyses were conducted. Height profiles were extracted from the flattened height data and can be seen
from the z direction in the height images and from the x,y direction below each image. These height profiles demonstrate how approximate feature heights
were determined for each sample. The determined feature heights were confirmed via particle analysis (Nanoscope version 5.30 r2 image analysis software)
shown at the bottom as a secondary technique to increase confidence in reported values.
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The immunoblot of the control monomer treated similarly also
showed a high molecular mass band that failed to enter the gel
(Fig. 5B, lane 2).
AFM images of the LFAO and control A42monomers sub-
jected to aqueous-organic solvent mixtures are shown in Fig. 6.
Large spheroidal aggregates with heights of 33 nm were
observed in LFAO samples treated with hexane (Fig. 6A and
supplemental Fig. S4A). These aggregates were at least 3–4
times larger in apparent diameter than the individual LFAO
molecules and appear to result fromLFAO association (Fig. 6A,
inset). Fibrillar structures were observed in A42 control
monomer samples treated with hexane (Fig. 6B). It is notewor-
thy that LFAOs failed to form the ringlike structures seen with
APFs (20), suggesting that different molecular organization
processes occur for different soluble oligomers. LFAO samples
treated with chloroform showed large clusters of aggregates
21 nm in height (Fig. 6C and supplemental Fig. S4C). How-
ever, no fibrillar material was observed in 42 monomers
treated with chloroform (Fig. 6D) despite the fact that a high
molecular mass band that failed to enter the gel was observed
for the same sample in the immunoblot (Fig. 5B, lane 2). It is
likely that dilution of the sample during the preparation proce-
dure forAFManalysis dissolved the unstable aggregates formed
in chloroform interfaces. This observation is similar to the one
reported by Nichols et al. (29) in which A40 generated unsta-
ble aggregates in a chloroform-buffer interface that were com-
pletely disaggregated upon dilution. The collective data show
that when LFAOs are exposed to aqueous-organic interfaces
large, non-fibrillar, disperse aggregates are formed. This sug-
gests that LFAOs assemble into aggregates that may not lie
along the fibril formation pathway.
Chloroform-Buffer Suspension Experiment—The agitation
experiments mentioned above cause rapid exchange of phases,
leading to increased surface area of interfaces, which in turn
FIGURE 4. Incorporation of Dan-A42 monomer into replicated oligo-
mers after seeding. A, schematic for incorporation of Dan-A42 into repli-
cated LFAOs after seeding for 72 h. B, SEC fractionation of 50 M Dan-A42
seeded with 1 M LFAO (2% seed) for 72 h at room temperature. C, immuno-
blot showing the comparison of seeded sample before and after SEC. Lane 1,
50 M Dan-A42 monomer (1.8 g); lane 2, LFAO seed (36 ng); lane 3, Dan-
A42 control in the absence of seeds after 72 h; lane 4, aliquot of the seeding
reaction immediately after incubation at 0 h; lanes 5 and 6, the total reaction
and supernatant of the reaction, respectively; lanes 7–9, SEC fractions 16, 17,
and 18 show replicated oligomers (arrows); lane 10, monomer fractionated in
the included volume (fraction 24). The LFAO seed amount of 36 ng was kept
constant in the immunoblot. D, fractionated sample. Fractions 16, 17, and 18
show the Dan-A42 emission at 450 nm upon exciting at 350 nm with both
excitation and emission slits set 10 nm each. The results are one of three
reproducible data sets. F, fluorescence; a.u., absorbance units.
FIGURE 5. LFAO agitation in interfacial environments. A, the increase in
size of LFAO after agitation with 5% (v/v) hexane or chloroform in buffer
followed by dialysis for 23 h was monitored by DLS. B, immunoblot of the
agitation experiments along with monomer controls. Lane 1 shows control
monomer A42. Lanes 2 and 3 show the 23-h dialyzed A42 monomer sam-
ple treated with chloroform and hexane, respectively. Lane 4 shows control
LFAO. Lanes 5 and 6 show 23-h dialyzed LFAO treated with chloroform and
hexane, respectively. The single and double arrows indicate 50 –70- and
80 –110-kDa bands, respectively.
FIGURE 6. Morphology of aggregates formed after treatment with chlo-
roform and hexane. A and B, AFM images of LFAO and monomer A42
control, respectively, agitated with hexane. A, LFAOs show the presence of
small globular aggregates and large clumps of aggregates. The inset shows a
1-m expansion of the aggregate indicated by the white arrow. B, control
monomers treated with hexane show the presence of fibrils. The inset shows
a 1-m expansion of the aggregate indicated by the white arrow. C and D,
AFM images of LFAO and monomer A42 control, respectively, agitated with
chloroform. C, LFAOs show the presence of several large clumps of aggre-
gates. The inset shows a 1-m expansion of the aggregates indicated by the
white arrows. D, control monomers treated with chloroform failed to show
the presence of any aggregates. The white scale bar represents 1 m, and the
square represents a 5  5-m field. The amplitude images are presented here
and the z scale is 0 – 0.8 V.
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affects association of LFAOs. Because agitation is in some
respects a harsh method of aggregation, we wanted to see
whether similar changes occurred in amilder formof interfacial
treatment by simply suspending the aqueous layer containing
A on top of a more dense chloroform layer. One such aque-
ous-organic phase suspension experiment has been reported in
which the buffer containing A40 was gently suspended on top
of a chloroform layer and aggregation was monitored (21).
These conditions led to a rapid aggregation of A40 peptide to
formboth globular and short, protofibril-like structures. A sim-
ilar procedure was followed for LFAOs, and within 2 h of incu-
bation, a monodisperse peak centered at 80 nm in diameter
emerged in DLS that increased to 150-nm peak in the next
24 h (Fig. 7A). A similar trendwas observed in the immunoblot of
the sample in which a band at 150 kDa was seen within 2 h of
incubation, andafter 24h, amuch largermolecularmass bandwas
observed that failed to enter the gel (Fig. 7B, lanes 4 and 5).
Numerous punctate dots of globular species with widely
varying heights (7–30 nm) were seen in the AFM image of the
same sample after 24 h of incubation (Fig. 7C and supplemental
Fig. S5A). The species resembled the LFAO aggregates
observed in the agitation experiments, but they were much
larger in size. In sharp contrast, control A42 monomers nei-
ther showed any significant increase in size as witnessed by
immunoblots (Fig. 7B, lane 2) nor showed morphology similar
to that of the LFAOs (Fig. 7D). In fact, the height of the particle
seen in the AFM image was smaller (6 nm) than that of pure
LFAOs (supplemental Fig. S5B). Interestingly, the globular par-
ticles observed with the monomer control were not seen on a
Western blot, and DLS did not indicate the presence of such a
species. Again, one possible explanation for this observation is
that the unstable aggregates formed in chloroform-buffer inter-
faces disaggregate upon dilution, generating monomeric A42
as observed previously (29). Nevertheless, the data clearly show
the absence of fibrillar material with LFAOs, complementing
our previous observations as well as our hypothesis that LFAOs
are formed along an alternative pathway of aggregation similar
to APFs and fibrillar oligomers observed by Kayed et al. (28).
DISCUSSION
In this report, we have shown that LFAOs are not discrete but
diffuse oligomeric species with a broadmolecularmass range of
56–110 kDa. Within this molecular mass range, two popula-
tions of LFAO species exist at 56–70 and 80–110 kDa, which
approximately translate to 12–15-mers and 18–24-mers. It is
fundamentally important to understand whether there are any
residual NEFAs associated with LFAOs as they may affect the
physiochemical properties of LFAOs. Our analysis indicated
that NEFAs are essentially absent in the isolated LFAO samples
(supplemental Fig. S1). It is also important to note that any
residual amount of NEFA, if present, may not influence A
aggregation properties as their concentration would be well
below its critical micelle concentration as reported previously
(1). AUC-sedimentation velocity data revealed that LFAOs are
mixtures of oligomers with sedimentation coefficients of 5 and
7–12 S and somemonomers. This observation is similar to that
reported for amyloid-derived diffusible ligands, which were
also found to be a heterogeneous mixture containing species
larger than 90 kDa that displayed a disperse c(s) distribution
between 10 and 25 S in sedimentation velocity experiments
(27). A sequential back-to-back SEC fractionation of LFAO
samples showed no significant reduction in the concentration
of monomers present in the sample, suggesting that LFAOs
undergo dissociation upon dilution (supplemental Fig. S2).
This further supports other findings that LFAOs are disperse
rather than discrete aggregates.
A significant feature of LFAOs is their replicating property,
which has potentially far reaching implications for AD pathol-
ogy. First, the observation of LFAOs acting as “seeds” to pro-
duce more of the non-fibrillar aggregates implies the conver-
sion of non-pathogenic species to potentially more toxic
strains, similar to a mechanism observed with prion diseases
(Fig. 8A) (30–34). The direct implication of this property in AD
is the possibility that the LFAOs can act as a “molecular sink” to
recruit more A monomers away from fibrils. Although quali-
tative analysis has revealed this important property of LFAOs, a
rigorous quantitative increase in the amount of LFAOs con-
verted could also be of profound practical application. Briefly,
by followingacyclic amplificationmethodsimilar to theone intro-
duced by Soto and co-workers (35, 36) for amplifying prion aggre-
FIGURE 7. Chloroform suspension experiment. A, LFAO was suspended
over 100% chloroform solution, and the sample was removed from above the
interface after 2 and 24 h to monitor the increase in size by DLS. DLS data
indicate that the size of LFAO (black peak) was shifted from 11.03 to 80 nm
in 2 h (light gray peak) and to 160 nm in 24 h (dark gray peak), indicating the
formation of large aggregates. B, immunoblot showing A42 monomer (M)
and LFAO sample removed from above the interface after 24 h. Lanes 1 and 2
show control A42 monomer and monomer sample removed from above the
interface (in the aqueous buffer side), respectively, after 24 h. Lanes 3 shows
control LFAO. Lanes 4 and 5 show the LFAO sample removed from above the
interface after 2 and 24 h, respectively. The single and double arrows indicate
50 –70- and 80 –110-kDa bands, respectively. C, AFM image of chloroform
interface sample after 24 h showing the presence of large clumps of aggre-
gates (white arrows). D, AFM image of control monomer treated with chloro-
form interface shows no appreciable aggregate structure. The white scale bar
represents 2.5 m. The amplitude images are presented here and the z scale
is 0 – 0.8 V.
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gates with a low concentration seed from a physiological source,
one will be able to “scale up” the amount of the seed using exoge-
nous monomers to the levels amenable for in vitro biophysical
analyseswhilepreserving the structural integrityof the source.We
are currently exploring this aspect and will report it later.
Comparison of LFAOs with Other Oligomers Indicates Simi-
larities and Differences—There are only a handful of reports on
the replication property of A oligomers, and of those, the
reports by Glabe and co-workers (20, 28, 37) are the most
recent. They identified three specific soluble oligomer subtypes
classified mainly on the basis of their immunoreactivity toward
conformation-specific antibodies. These subtypes are PFOs,
fibrillar oligomers (FOs), and APFs, and they are recognized by
the conformation-specific antibodies A11, OC, and PF,
respectively (28). Among these, both PFOs and FOs showed a
self-replication property by converting monomers into oligo-
mers of the same type (28, 38). The main distinction between
PFOs and FOs is that the PFOs are recognized by the polyclonal
antibody A11, whereas the FOs are detected by the fibril-spe-
cific antibody OC (39). Our attempts to detect LFAOs with the
oligomer-specific antibodyA11 did not yield conclusive results.
Although we could not get a positive signal with A11 for
LFAOs, it would be inconclusive to say LFAOs may be struc-
turally different from the epitope recognized by A11 as we
could not generate appropriate positive controls for A11-spe-
cific oligomers even after several attempts. Nevertheless, a bio-
chemical difference between the two oligomers is that FOs
resemble fibril structure and seed fibril formation, whereas
PFOs do not. The LFAOs reported here seem to resemble FOs
rather than PFOs based onmorphological heights, which range
between 5 and 15 nm for FOs (38) as compared with 8–13 nm
reported here for LFAOs. However, further comparative anal-
yses of LFAOswith other self-replicating oligomers such as FOs
could not be made largely due to the paucity of stringent bio-
physical investigations of the replication process. On the other
hand, the APFs that are generated from hexane-water inter-
faces are characterized by a unique porelike structure that leads
to membrane permeabilization and disruption of ion homeo-
stasis, causing cell death (40). As shown in Fig. 6, similar treat-
ment of LFAOs with hexane-water and chloroform-water
interfaces failed to generate ringlike structures similar to APFs.
Perhaps this difference is due to the fact that LFAOs are more
similar to FOs than PFOs, and APFs are generated from PFOs.
Physiochemical Properties of LFAOs Showcase Reactions
alongOff-fibril Formation Pathway—This report also reiterates
the fact previously reported by us and many others that oligo-
mers need not be formed along the obligatory fibril formation
pathway. The one important trait of all the oligomers discussed
above such as FOs and PFOs is that they could nucleate the
formation of oligomers frommonomers but not fibrils (28, 38).
Our current report also suggests that both interaction of
LFAOs with monomers and association with similar oligomers
lead to the formation of more non-fibrillar products. Not only
are LFAOs formed along an alternative pathway, but they are
also able to compete anddivertmonomers from the nucleation-
dependant fibril formation pathway (Fig. 8B). Furthermore,
association of LFAOs with each other in the presence of inter-
faces led to the formation of larger but non-fibrillar aggregates.
This association property of LFAOs provides valuable insight
into the potentially similar behavior of endogenous LMWolig-
omers in the presence of lipid interfaces in physiological envi-
ronments. These data indicate that there may be many energy
minimum states along the aggregation landscape (as depicted
in Fig. 8B), and therefore, there is a likelihood of oligomers
getting trapped in a “kinetic minimum” along the aggregation
landscape and thus eliciting prolonged toxicity. Therefore, it is
not unrealistic to hypothesize that the nucleation-dependant
pathway could potentially be a “less pathogenic route” com-
pared with the alternate pathway(s) that populates LMW olig-
omers. Future experiments will test this hypothesis.
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FIGURE 8. Schematic diagram depicting generation of off-pathway olig-
omers and replication. A, the classic on-pathway fibril formation process is
depicted along with an alternative off-pathway. The process of replication
undergone by off-pathway oligomers is shown in dotted lines. B, the aggrega-
tion process is shown as a thermodynamic funnel for intrinsically disordered
proteins such as A toward fibril formation. This path is considered to be the
nucleation-dependant on-pathway. The spherical and oval balls represent
LMW oligomers. However, the oligomers may adopt a different pathway such
that they are trapped in local energy minima as off-pathway species (oval
balls; gray area of the funnel). Such off-pathway species would have a signif-
icant energy barrier to overcome to proceed toward fibrils. Also, the off-path-
way oligomers can recruit more monomers, which dictates them to adopt
such alternate pathways (replication process shown in A). This may further
increase the energy barrier for replicated off-pathway oligomers to overcome
while significantly increasing their half-lives.
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Figure S1. Quantitation of NEFA content in isolated LFAOs.  The amount of NEFA 
associated with LFAOs before and after SEC was estimated using free fatty acid quantification 
kit (Biovison Inc., catalog #  K612-100) as reported previously (1). The experiment was 
performed as per the manufacturer’s instructions.  In brief, a standard curve was generated 
adding 2 L aliquots of known concentrations of palmitic acid to each well containing the 
reaction mixture provided by the manufacturer ().  The reactions were monitored 
calorimetrically at 570 nm. The concentration of NEFA present in 2 L aliquots of LFAOs 
before (; pre SEC) or after (; post SEC) isolation by SEC were estimated using the standard 
curve.  Based on this analysis, the NEFA concentration before SEC was estimated to be 4.5 mM, 
which is comparable to the 5 mM used.   On the other hand for the isolated LFAO, a negligible 
amount of NEFA was detectable in the sample, suggesting a complete removal of NEFAs from 
the LFAOs upon fractionation.   
 by V
ijay R










Figure S2. Quantification of LFAO and monomer after SEC.  
The LFAOs are generated and isolated as mention in Materials and Method (Run 1). The peak 
fractions 17 & 18 were pooled and loaded on to the SEC column for the second round of 
fractionation (Run 2). The concentration of the peak fraction was used to normalize the 
chromatogram and the area under the curve was used to calculate % yield.  In Run 1, 89.7 % of 
LFAOs and 10.6 % monomer was obtained, while in Run 2, 92.7 % LFAOs and 7.3 % monomer 






























Figure S3. AUC of monomer and fibril. A c(s) distribution profile generated from 




























Supplemental Figure S4. AFM height analyses of samples shown in Figure 6 after 
treatment with chloroform and hexane.  A & B) LFAO and monomer Aβ42 control, 
respectively, agitated with hexane.  A) LFAOs show the presence of small globular aggregates 
and large clumps of aggregates.  B) Control monomers treated with hexane show the presence of 
fibrils. C & D) AFM images of LFAO and monomer Aβ42 control, respectively, agitated with 
chloroform.  C) LFAOs show the presence of several large clump of aggregates.  D) Control 
monomers treated with chloroform failed to show the presence of any aggregates. The white box 
shows the particles for which sectional and particle analysis were performed, which are listed in 
a tabular form below.   The blank cells in the table suggest the data was not acquired.  The white 
scale bar represents 2.5 μm and the square represent 5 x 5 μm field.  The z-scale for all images is 
0-40 nm.  The determined feature heights were confirmed via particle analysis (Nanoscope 















Supplemental Figure S5.  AFM height analyses of chloroform suspension experiment 
shown in Figures 7C and 7D.  A) AFM height image of LFAO sample treated with chloroform 
interface for 24 h, showing the presence of large clumps of aggregates, and B) similar height 
image of control monomer treated with chloroform interface shows no appreciable aggregate 
structure. The white scale bar represents 2.5 μm.  Height profiles were extracted for each image 
to determine feature height and can be found below its corresponding image.  The determined 
feature heights were confirmed via particle analysis (Nanoscope version 5.30 r2 image analysis 
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